Limba
Romanian
Romanian
English|
Belzutifan (PT2977), an orally active and selective HIF-2αinhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC).
| Price | 2.884,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Belzutifan (PT2977), an orally active and selective HIF-2αinhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC). |
